Health Subjects
8
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
The Effect of Food on the Pharmacokinetics of BN104 Tablets
Echo-guided Percutaneous Electrical Nerve Stimulation of the Femoral Nerve
A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects
A Study of A4368 in Healthy Subjects
A Food Effect Phase I Study of the Volitinib in Healthy Subjects
A Food Effect Study of Besifovir in Healthy Subjects